Tuesday, May 30, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Hyderabad | Bharat Biotechs Covaxin Shows 77 8 Pc Efficacy In Phase Iii Trials

Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials

Bharat Biotech's 'pre-submission' meeting with the World Health Organization (WHO) will take on Wednesday for the approval for Covaxin.

By ANI
Published Date - 04:28 PM, Tue - 22 June 21
Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials
Representational Image.
whatsapp facebook twitter telegram

New Delhi: Bharat Biotech’s Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.

The Hyderabad-based COVID vaccine manufacturing company had submitted data from the Phase III clinical trials of Covaxin to the Drugs Controller General of India (DCGI) over the weekend.

Bharat Biotech’s ‘pre-submission’ meeting with the World Health Organization (WHO) will take on Wednesday for the approval for Covaxin.

Covaxin is one of the three vaccines which are currently being used in India. The phase III data of its vaccine has been questioned various times and this is what makes the data that ascertains the efficacy of the vaccine crucial.

The company has developed the vaccine in association with the Indian Council of Medical Research (ICMR).


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Bharat Biotech (BB)
  • Covaxin
  • Drugs Controller General of India (DCGI)
  • Indian Council of Medical Research (ICMR)

Related News

  • Telangana government to provide booster dose from April 19

    Telangana government to provide booster dose from April 19

  • Telangana’s Genome Valley nurtures startups into MNCs

    Telangana’s Genome Valley nurtures startups into MNCs

  • Covishield immune responses against Covid variants higher than Covaxin: Study

    Covishield immune responses against Covid variants higher than Covaxin: Study

  • Bharat Biotech, MoHFW deny rush, political pressure in regulatory approval for Covaxin

    Bharat Biotech, MoHFW deny rush, political pressure in regulatory approval for Covaxin

  • CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

    CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

  • Editorial: A game changer

    Editorial: A game changer

Latest News

  • Mahindra announces Thar 5-door launch date

    4 mins ago
  • Hyderabad: Jubilee Hills pub responds to criticism over exotic wildlife display

    17 mins ago
  • ChatGPT, electronic devices used to cheat in TSPSC exams

    25 mins ago
  • Biryani reigns supreme with 212 orders per minute this IPL season

    38 mins ago
  • AP govt. issues GO to CID to attach assets worth Rs 793 crore of Margadarsi Chit Fund

    47 mins ago
  • WhatsApp introduces ‘status archive’ feature for businesses on Android

    53 mins ago
  • YS Jagan Mohan Reddy to hold cabinet meeting on June 7

    1 hour ago
  • Devotees rush continues in Tirumala; 22 hours for Sarvadarshanam

    29 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam